ABSTRACTS
Midwest SPR is committed to presenting the broadest possible range of high-quality work at the 2026 Scientific Meeting.
• Historically, abstracts accepted for presentation are hypothesis-driven new work.
• Abstracts rarely accepted for presentation include open-label drug trials, single case reports, highly speculative accounts of clinical experience, and op-ed accounts of personal experience.
• Interim results from an ongoing clinical trial will not be accepted for presentation unless the study has been prematurely closed for efficacy, lack of efficacy, or issues of safety.
• If the abstract is selected, the presentation must include the methods used for study and any other information relevant to research.
• There is no limit on the number of abstracts submitted by each author, but the submission of multiple, similar abstracts from the same investigator(s) or laboratory is strongly discouraged.
• Only High School Students, Medical Students, Residents, or Fellows are eligible for Works in Progress (WIP).